We are conducting a research study for people with type 2 diabetes who are currently taking insulin glargine (ex: Lantus Solostar) and metformin. This research study will evaluate the effectiveness and safety of using semaglutide once weekly as an add-on treatment.

You may be eligible if you:

• Are 18 or older
• Are diagnosed with type 2 diabetes
• Have a BMI of 25 or greater
• Are taking daily metformin ≥1500 mg or maximally tolerated dose
• Are taking once-daily insulin glargine (ex: Lantus Solostar) < 40 units per day

There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive all study-related investigational drug, procedures, and medical exams at no cost, as well as a stipend for time and travel. No health insurance is required to participate.

For more information call

(904) 730-0166

Or sign up below, and our office will call you!